European Pharmaceutical Review

NOVEMBER 25, 2024

The market is furthermore expected to see a compound annual growth rate (CAGR) of 7.3 percent between 2024 and 2032. percent market share between 2024 and 2032, based on the forecast by Straits Research. Their analysis projected that the market will exceed a value of $15.46 billion by 2032.

Drug Development 52

Drug Development Biosimilars Compounding Pharmaceutical Companies 52

Pharmacy Times

DECEMBER 24, 2024

Despite the explosion of public interest in these drugs, ongoing shortages and debates over compounding made access difficult.

Compounding 55

Compounding 55

Pharmaceutical Technology

AUGUST 27, 2024

OUD is a chronic neurological disorder described as the consequences associated with repeated, compulsive use of opioid drugs.

Compounding 52

Compounding 52

epicur

NOVEMBER 26, 2024

Our sister division, Stokes Pharmacy, and the Bova Group have almost parallel stories—pharmacies with retail roots that expanded into compounding to better serve a larger audience with the highest quality medications possible. What sets Bova apart from other compounders? It was amazing to be a part of.

Compounding 52

Compounding Compounding Pharmacies Communication Hospitals 52

European Pharmaceutical Review

AUGUST 3, 2023

EPC’s new Cannabis flower monograph The new monograph Cannabis flower (Cannabis flower, monograph 3028) will be available next year in January 2024 with publication of the supplement 11.5. The monograph will enter into force several months later, in July 2024. 1 July 2024).

Compounding 98

Compounding Pharmaceutical Companies Pharmaceutical Companies 98

Express Pharma

MARCH 25, 2024

The agreement includes Cardior’s lead compound CDR132L, currently in phase 2 clinical development for the treatment of heart failure. The closing of the acquisition is subject to receipt of applicable regulatory approvals and other customary conditions and is expected to happen in the second quarter of 2024.

Compounding 110

Compounding Communication 110

European Pharmaceutical Review

JUNE 5, 2024

As such, the compound annual growth rate (CAGR) is expected to be 12.8 Major trends in the small molecule injectable drugs market Based on the forecast, key trends projected for 2024 to 2033 include innovations in technology, drug delivery systems, injectable therapies, R&D, as well as fast-track approvals of new drug formulation.

Compounding 97

Compounding Diabetes 97

Digital Pharmacist

DECEMBER 22, 2023

Recognizing and addressing these changing dynamics is crucial as we step into 2024. Digital Transformations As in the past years, one of the top pharmacy trends of 2024 remains to be “digital.” The post 2024 Pharmacy Trends to Look For appeared first on Digital Pharmacist.

Community Pharmacies 52

Community Pharmacies Prescription Filling Medication Delivery Packaging 52

PharmaTech

OCTOBER 25, 2024

The laboratory is on the same site as BioDuro-Sundia’s new Compound Management Center, which was launched earlier in October 2024.

Compounding 59

Compounding 59

PharmaTech

JANUARY 13, 2025

This is the latest facility launch for BioDuro, following a kilogram laboratory and compound management center, both on the same site, in October 2024.

Compounding 59

Compounding 59

Express Pharma

JANUARY 14, 2025

per cent from 2024 to 2030. billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.3 billion in 2023 and is expected to grow at a CAGR of 8.4 Whereas the global vitamin supplements market size was estimated at $48.51 per cent from 2023 to 2030.

Diabetes 105

Diabetes Compounding 105

European Pharmaceutical Review

NOVEMBER 27, 2023

The compound has a similar function to an antibody, binding and neutralising harmful fAABs. Long COVID drug candidate BC 007 As a platform technology, BC 007 has the potential to cure different autoimmune diseases by targeting fAABs as their root cause, Berlin Cures stated.

Compounding 130

Compounding 130

European Pharmaceutical Review

MARCH 15, 2024

The market is set to witness a compound annual growth rate (CAGR) of 9.7 percent of the market share in 2024, the report stated. percent of the market share in 2024. According to research published by Coherent Market Insights, the global mycoplasma testing market is anticipated to reach $1,907.6 million by 2031.

Compounding 98

Compounding 98

The Happy PharmD

NOVEMBER 19, 2024

Pharmacies are closing at an alarming rate in 2024, and the consequences are shaking the very foundation of healthcare in this country. This lack of interest could lead to a staffing shortage in the future, further compounding the challenges in pharmacy. But it’s not all doom and gloom.

Mail-Order Pharmacies 52

Mail-Order Pharmacies Independent Pharmacies Compounding Hospitals 52

Express Pharma

MAY 30, 2024

The World Health Organization stated in March 2024 that “over 80 per cent of neurological deaths and health losses occur in low- and middle-income countries, and access to treatment varies widely.” billion in 2030, with a compound annual growth rate (CAGR) of 117.6 per cent.

Compounding 115

Compounding Diabetes Pharmaceutical Companies Pharmaceutical Companies 115

Pharmacy Is Right For Me

JULY 23, 2024

This camp gave me a real taste of what being a pharmacist entails as I compounded medications and completed various patient care simulations. One easy way to visit many pharmacy schools from the comfort of your own home is to attend the Virtual Pharmacy School Fair on September 25, 2024 from 10am – 5pm EST! Register today!

Compounding 246

Compounding Hospitals 246

European Pharmaceutical Review

OCTOBER 25, 2024

The compound was designed to address issues such as payload toxicity seen in first-generation ADC therapies, according to Zai Lab. This initial data on ZL-1310 was presented this week at the EORTC-NCI-AACR (ENA) Symposium 2024. ZL-1310 is humanised anti-DLL3 monoclonal antibody with a topoisomerase 1 inhibitor payload.

Chemotherapy 97

Chemotherapy Compounding Immunization Immunity 97

pharmaphorum

AUGUST 25, 2022

billion by 2024. Novartis started a review of the business in October 2021, after Sandoz had been suffering from pressure on sales and operating profits for several years due mainly to pricing pressures, which were then compounded by the pandemic.

Biosimilars 105

Biosimilars Compounding Vaccines 105

European Pharmaceutical Review

MAY 7, 2024

percent compound annual growth rate (CAGR) between 2024 to 2029. A new report by MarketsandMarkets has predicted that the injectable drug delivery market will reach an 8.6 The market is anticipated to value $1139.4 billion by 2029.

Vaccines 94

Vaccines Compounding Immunization Immunity 94

pharmaphorum

AUGUST 2, 2022

The potential for ADCs to combine the best of both mAbs and small molecule drugs means that there has been high interest in developing a successful compound since the first successful clinical trial in 1983. Development of the compound was subsequently ended. billion in revenue last year. Not all rosy.

Compounding 98

Compounding Drug Development 98

European Pharmaceutical Review

NOVEMBER 28, 2024

Undefined terms like “undue delay” and “disproportionate effort” add layers of uncertainty, which are further compounded by the fact that enforcement will rely on varying capacities and interpretations, as the EU relies on 27 independent data protection authorities 3 to enforce regulations.

Documentation 105

Documentation Compounding 105

Pharmaceutical Business Review

OCTOBER 24, 2024

The CRL, dated 22 October 2024, comes ahead of the Generic Drug User Fee Amendments of 2022 (GDUFA) goal date set for 29 October 2024. Ketamine, an essential medicine for anaesthesia and analgesia, is listed on the WHO Essential Medicines List and approved by Health Canada for use as a sedative and painkiller in hospitals.

Compounding 52

Compounding Hospitals 52

Express Pharma

JANUARY 11, 2024

The sales growth of gout therapies across the seven major markets (7MM: the US, 5EU, and Japan) is set to increase at a compound annual growth rate (CAGR) of 8.8 With Ilaris’ US patent expiring in 2024, this biosimilar is anticipated to enter the market and potentially diminish Ilaris’ share. per cent from $4.6

Biosimilars 103

Biosimilars Compounding 103

European Pharmaceutical Review

APRIL 25, 2024

Four key barriers to female career progression were explored during a panel at the UK 2024 Advanced Therapies conference in March. Jones summarised how a lack of confidence can be compounded in the cell and gene therapy sector, given it is such a changing industry: “often you are out of your comfort zone”. cited 2024Apr].

Compounding 105

Compounding 105

Express Pharma

JUNE 7, 2024

billion by 2030, at a compound annual growth rate (CAGR) of 4.7 The main treatments for MS focus on slowing the disease’s progression and are disease-modifying therapies (DMTs). According to GlobalData’s forecast on the multiple sclerosis market size, it is expected that sales for MS DMTs will grow to $30.1 per cent during 2020 -30.

Compounding 80

Compounding 80

European Pharmaceutical Review

JANUARY 29, 2024

It is to be hoped that this will be addressed by an update of the ICH M7(R2) guidance during 2024 ICH M7(R2) 10 currently provides some guidance to establish AIs for mutagenic impurities. It is to be hoped that this will be addressed by an update of the ICH M7(R2) guidance during 2024. Accessed on 02 January 2024. August 2023.

Drug Development 111

Drug Development Vaccines Compounding 111

Pharmaceutical Technology

NOVEMBER 1, 2022

The merged business’ cash resources are estimated to offer Intrinsic the capital to progress its lead compound, OM002, and other pipeline assets. These resources will also be used to fund a Phase IIb clinical trial of OM002 in more than 400 subjects with constipation dominant form of irritable bowel syndrome (IBS-C).

Compounding 59

Compounding 59

Big Molecule Watch

JANUARY 17, 2024

collectively, “Alexion”) filed a complaint on January 3, 2024, against Samsung Bioepis Co. 9,732,149, directed to the antibody eculizumab that is the active compound in SOLIRIS; U.S. Alexion Pharmaceuticals, Inc. and Alexion Pharma International Operations Ltd. Samsung”) in the U.S. 262(l)(8)(A). Patent Nos.

Biosimilars 65

Biosimilars Compounding 65

FDA Law Blog: Biosimilars

DECEMBER 3, 2023

As part of this change, the Coverage Gap Discount Program (CGDP), a program that has existed since 2011, will sunset on December 31, 2024, and be replaced by the Medicare Part D Manufacturer Discount Program (the “Discount Program”). Manufacturers must sign the agreement by March 1, 2024, to participate in the 2025 plan year.

Labelling 105

Labelling Drug Pricing Compounding Payment Processing 105

Pharmaceutical Technology

APRIL 21, 2023

Enveda Biosciences intends to use the additional financing to advance several candidates derived from its drug discovery platform to clinical development in 2023 and 2024. Existing investors include Wireframe, True Ventures, FPV and Dimension. The candidates are indicated across fibrosis and neurosensory and inflammatory diseases.

Compounding 59

Compounding 59

European Pharmaceutical Review

JANUARY 25, 2024

Over time, these can leach “low molecular weight compounds” such as plasticisers, stabilisers and binding agents from CCS components or from labelling components, like inks or adhesives into the drug product. The guidance document also emphasised semipermeable CCSs as another factor to consider in relation to E&Ls.

Documentation 98

Documentation Method Validation Packaging Labelling 98

Pharmacy Times

JANUARY 16, 2025

Farah Towfic, PharmD, MBA, RPh, discusses how US Pharmacopeia helped to strengthen supply chain resilience in 2024 through data-driven insights, policy advocacy, and pharmacist engagement to address prolonged drug shortages, particularly for generic sterile injectables.

Compounding Pharmacies 26

Compounding Pharmacies Compounding 26

Putting Patients First Blog

JANUARY 29, 2024

Beyond Glaucoma: Empowering Lives Through Community January 29, 2024 By: Nita Sinha, Director of Public Health at Prevent Blindness A chronic disease, especially a progressive one such as glaucoma, can alter an individual’s life in unwelcomed ways. For more information on NHC membership, please email membership@nhcouncil.org.

Compounding 56

Compounding 56

epicur

MAY 6, 2024

But if it’s completely unavailable, start by looking at alternatives, whether compounded or a similar product. Ann has been a longstanding Epicur and Stokes Pharmacy advisor and she advocates for the education of compounding and 503B education in veterinary medicine. Thanks for sharing these great tips, Nicole!

Customer Service 52

Customer Service Compounding Chemotherapy Online Pharmacies 52

RX Note

FEBRUARY 4, 2024

Introduction In parallel with industrialization, the focus of pharmacists' practice has evolved from compounding and dispensing medications to the provision of professional services for patients. As experts in medicines, pharmacists can review complex medicine regimens and identify causes of problems and resolve them. Watson et al.

Community Pharmacies 52

Community Pharmacies Medical Records Compounding Diabetes 52

ID Stewardship

OCTOBER 14, 2024

BCPS, BCIDP Article Posted October 2024, First Released in the October 2024 IDstewardship Newsletter 1. Compounding sulbactam-durlobactam Admittedly I have never compounded this one myself, but it just sounds like an error waiting to happen as well as a considerable time commitment. Authored By: Timothy P.

Labelling 52

Labelling Compounding Packaging Hospitals 52

PharmaShots

MAY 5, 2023

BRCs’ initial testing is expected to be initiated for the patients at the end of 2024 Ref: Businesswire | Image: bicycle-therapeutics Related News:- Bicycle Therapeutics Signs a Collaboration Agreement with Novartis to Develop and Commercialize Multiple Targeted Bicycle Radio-Conjugates Therapies PharmaShots!

Compounding 40

Compounding 40